Skip to main content
main-content

10.08.2019 | Skeletal Biology and Regulation (M Forwood and A Robling, Section Editors) | Ausgabe 5/2019

Current Osteoporosis Reports 5/2019

Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown

Zeitschrift:
Current Osteoporosis Reports > Ausgabe 5/2019
Autoren:
Martha Blank, Natalie A. Sims
Wichtige Hinweise
This article is part of the Topical Collection on Skeletal Biology and Regulation

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Purpose of Review

We outline the diverse processes contributing to bone mineralization and bone matrix maturation by describing two mouse models with bone strength defects caused by restricted deletion of the receptor tyrosine kinase ligand EphrinB2.

Recent Findings

Stage-specific EphrinB2 deletion differs in its effects on skeletal strength. Early-stage deletion in osteoblasts leads to osteoblast apoptosis, delayed initiation of mineralization, and increased bone flexibility. Deletion later in the lineage targeted to osteocytes leads to a brittle bone phenotype and increased osteocyte autophagy. In these latter mice, although mineralization is initiated normally, all processes involved in matrix maturation, including mineral accrual, carbonate substitution, and collagen compaction, progress more rapidly.

Summary

Osteoblasts and osteocytes control the many processes involved in bone mineralization; defining the contributing signaling activities may lead to new ways to understand and treat human skeletal fragilities.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 5/2019

Current Osteoporosis Reports 5/2019 Zur Ausgabe

Cancer-induced Musculoskeletal Diseases (E Keller and J Sterling, Section editors)

Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets

Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)

Osteoglycin and Bone—a Systematic Review

Epidemiology and Pathophysiology (F Cosman and D Shoback, Section Editors)

The Role of Lower-Limb Geometry in the Pathophysiology of Atypical Femoral Fracture

Cancer-induced Musculoskeletal Diseases (E Keller and J Sterling, Section editors)

Breast Cancer Dormancy in Bone

Therapeutics and Medical Management (S Jan de Beur and B Clarke, Section Editors)

When Low Bone Mineral Density and Fractures Is Not Osteoporosis

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Orthopädie und Unfallchirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise